KMD-3213, a novel α1A-adrenoceptor antagonist, potently inhibits the functional α1-adrenoceptor in human prostate

SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

O. ARUNLAKSHANA, H. O. Schild · British Journal of Pharmacology and Chemotherapy · 1959 · 4K citations · Full text

Medicine, Pharmacology, General Pharmacology +16

Identification, Quantification, and Localization of mRNA for Three Distinct Alpha₁Adrenergic Receptor Subtypes in Human Prostate

David T. Price, Debra A. Schwinn, Jon W. Lomasney et al. · The Journal of Urology · 1993 · 322 citations

Medicine, Endocrinology, Molecular Biology +7

KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.

Kana Shibata, Rudolf Foglar, Kuniko Horie et al. · Molecular Pharmacology · 1995 · 230 citations

Medicine, Medicinal Chemistry, Pharmacology +13

RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.

Anthony Ford, Nicolas F. Arredondo, David R. Blue et al. · Molecular Pharmacology · 1996 · 193 citations

Medicine, Pharmacology, Urology +13

Use of an α1-Blocker, YM617, in the Treatment of Benign Prostatic Hypertrophy

Kazuki Kawabe, Akira Ueno, Yukie Takimoto et al. · The Journal of Urology · 1990 · 182 citations

Medicine, Pharmacology, Pharmacotherapy +13